Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.

Nina Raben(APT Therapeutics (United States)), Jürgen J. Heinisch(Osnabrück University), Hideaki Nakajima(Yokohama City University), Jeffrey B. Sherman(National Institutes of Health), R Exelbert, Paul H. Plötz(National Institutes of Health), Roland Spiegel(National Institutes of Health)
PubMed
January 1, 1995
Cited by 60

Related Papers

Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367